Proteus

Timeline

Savage-Thompson Management Founded

05/03/1988

Receive MBA’s

05/19/1989

Form CardioRhythm

may 5, 1991

Sell CardioRhythm for $45 Million

may 5 1992

may 6 1992

Co-Found FemRX

may 6, 1994

FemRx registers for IPO, later acquired by J&J for $22 million

may 5, 1996

Spring Ridge Ventures (SRV) formed ($1.5 million Series A)

may 5, 2000

Proteus founded

may 5, 2001

Choose to pursue pushing its CRT technology

november 11 2001

Approach companies with MEL prototype

may 6 2003

Raises $11 million Series B (4 different investors)

June 2004

Zdeblick develops IEM

may 2005

License MEL Technology to first CRT partner

may 2006

Raises $32.7 million in Series C

June 2006

O-Reilly hired to create business plan for IEM platform

January 2007

Meet with dozens of Pharma companies

may 2007 - july 2008

Completes first milestone from non-exclusive agreement

November 2007

Manufacturing facility now operational

january 2008

Signs development agreement with a second CRT partner

June 2008

$30 million Series D round

june 2008

Completed manufacturing and supply agreement with first partner

june 2008

EMITTER 1.0 Study

july 2008

PROMITTER study

august 2008

EMITTER 2.0 study

October 2008

EMITTER 3.0

February 2009

$24 million exclusive agreement with Novartis

January 2010

Receives 510 (k) clearance for Raisin Personal Monitor

april 2010

Receives CE Mark in E.U. for IEM

august 2010

Patent for digital health system granted

January 2012

Deal with Lloyds Pharmacy in UK for first raisin commercial product

january 2012

Exclusive agreement with Otsuka Pharma

July 2012

Receives FDA 510 (k) de novo clearance for IEM

July 30 2012

Deal for U.K.-based manufacturing site

march 2013

$62.5 million Series F round

may 2013